2005Cochrane Database of Systematic ReviewsRequires access

Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C

Marija Šimin, Jesper Brok, Davor Štimac, Christian Gluud, Lise Lotte Gluud

Open publisher page 5 citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C.

About this research paper

What this paper is about

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C.

Key concepts: Ribavirin, Pegylated interferon, Medicine, Chronic hepatitis, Interferon, Virology, Hepatitis C, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C — Research Paper | ScholarLens